Psychemedics, a global leader in the drug screening industry, has “proudly” announced the launch of a “revolutionary” drug screening panel that removes marijuana and emphasizes fentanyl.
According to a press release, this “groundbreaking offering will transform the way organizations safeguard their workplaces, shifting the spotlight from marijuana to the paramount threat of fentanyl.”
Complemented by the detection of cocaine, opioids, PCP, and amphetamines, the advanced panel is “a leap forward” in drug screening technology.
Continue reading